The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I mean we know that if I mean what Frank Sachs paper showed is if you take patients with low triglycerides and I believe he used a cut-off of 130 milligrams per deciliter 38% were de novo secreted by the liver sixty-two percent came from either IDL or VLDL where you had de novo I don't think the paper differentiated between which ones went ideal to LDL versus VLDL to ideal to LDL so that's an important point
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.